Boule Diagnostics (Sweden) Today
| BOUL Stock | SEK 9.56 0.02 0.21% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Boule Diagnostics is selling for under 9.56 as of the 18th of April 2024; that is -0.21 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 9.22. Boule Diagnostics has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Boule Diagnostics AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of October 2023 and ending today, the 18th of April 2024. Click here to learn more.
Boule Diagnostics AB , a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. Boule Diagnostics AB was founded in 1956 and is headquartered in Spnga, Sweden. Boule Diagnostics operates under Image Processing classification in Sweden and is traded on Stockholm Stock Exchange.. The company has 38.83 M outstanding shares. More on Boule Diagnostics AB
Moving together with Boule Stock
| 0.64 | ERIC-A | Telefonaktiebolaget | PairCorr |
Moving against Boule Stock
| 0.8 | SKA-B | Skanska AB | PairCorr |
| 0.79 | SWED-A | Swedbank AB Earnings Call This Week | PairCorr |
| 0.79 | ATCO-A | Atlas Copco AB Earnings Call This Week | PairCorr |
| 0.77 | VOLV-A | AB Volvo | PairCorr |
| 0.76 | VOLV-B | AB Volvo | PairCorr |
| 0.74 | SEB-A | Skandinaviska Enskilda Earnings Call This Week | PairCorr |
| 0.7 | BORG | Bjorn Borg AB | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Boule Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boule Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boule Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Pres | Ernst Westman |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) |
Boule Diagnostics AB (BOUL) is traded on Stockholm Exchange in Sweden and employs 200 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 532.01 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boule Diagnostics's market, we take the total number of its shares issued and multiply it by Boule Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boule Diagnostics operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 38.83 M outstanding shares.
Boule Diagnostics AB has accumulated about 38.18 M in cash with 43.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.87.
Check Boule Diagnostics Probability Of Bankruptcy
Ownership AllocationBoule Diagnostics retains a total of 38.83 Million outstanding shares. Boule Diagnostics AB shows significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Boule Diagnostics AB stock in recent months. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Boule Ownership Details
Boule Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Boule Diagnostics jumping above the current price in 90 days from now is about 80.33%. The Boule Diagnostics AB probability density function shows the probability of Boule Diagnostics stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Boule Diagnostics has a beta of 0.4176 suggesting as returns on the market go up, Boule Diagnostics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Boule Diagnostics AB will be expected to be much smaller as well. Additionally, boule Diagnostics AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Boule Diagnostics to move above the current price in 90 days from now is about 80.33 (This Boule Diagnostics AB probability density function shows the probability of Boule Stock to fall within a particular range of prices over 90 days) .
Boule Diagnostics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Boule Diagnostics market risk premium is the additional return an investor will receive from holding Boule Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Boule Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Boule Diagnostics' alpha and beta are two of the key measurements used to evaluate Boule Diagnostics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.12 | |||
| Standard Deviation | 3.17 | |||
| Variance | 10.07 | |||
| Risk Adjusted Performance | (0.04) |
Boule Stock Against Markets
Picking the right benchmark for Boule Diagnostics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Boule Diagnostics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Boule Diagnostics is critical whether you are bullish or bearish towards Boule Diagnostics AB at a given time. Please also check how Boule Diagnostics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boule Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Boule Diagnostics Corporate Directors
Boule Diagnostics corporate directors refer to members of a Boule Diagnostics board of directors. The board of directors generally takes responsibility for the Boule Diagnostics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Boule Diagnostics' board members must vote for the resolution. The Boule Diagnostics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Thomas Eklund | Director | Profile | |
| Hans Johansson | Production Director | Profile | |
| Charlotta Falvin | Director | Profile | |
| Karin Dahllof | Director | Profile |
How to buy Boule Stock?
Before investing in Boule Diagnostics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Boule Diagnostics. To buy Boule Diagnostics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Boule Diagnostics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Boule Diagnostics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Boule Diagnostics AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Boule Diagnostics AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Boule Diagnostics AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Boule Diagnostics AB?
The danger of trading Boule Diagnostics AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Boule Diagnostics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Boule Diagnostics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Boule Diagnostics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boule Diagnostics AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Boule Stock analysis
When running Boule Diagnostics' price analysis, check to measure Boule Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boule Diagnostics is operating at the current time. Most of Boule Diagnostics' value examination focuses on studying past and present price action to predict the probability of Boule Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boule Diagnostics' price. Additionally, you may evaluate how the addition of Boule Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |